| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > The Who, What, Where and When of Color In Your Documents |
|
Just Other Articles - The Who, What, Where and When of Color In Your Documents
This article will help you to assess and maximise the impact your use of color in your documents and presentations will have on the readers. First of al According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product l you need to identify the following;
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Who and What? Determine who your target readers are and what the specific purpose of the document is. Is it an internal product for your emplo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ees or is it for the eyes of potential or existing customers. What is the purpose? Is it to advise, explain, sell, market etc. How many documents are i here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe volved? Is it just documents or are multimedia presentations needed. What results are you expecting? All these parameters need to be covered. Are your d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro arget audiences conservative or more open to vibrant colors in documents and presentations. Some cultures associate serious business messages with black ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and white. Just give your specific situation some thought. When and Where? If you are sending a marketing proposal document to a client you wil easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi l be looking to impress your existing or potential. But beware, the use of bright, fluorescent colors might not go down too well with a firm of accounta nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ts or lawyers but may well be appreciated by a music/video company. If it is an internal document, do you need to use color at all? Consider the cost i and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ plication of doing this - Ink cartridge and laser toner usage etc. Unless the purpose of the document is, for example, to explain some major change in c ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi mpany structure, then I suggest you keep to black and white or minimise the color involved. A situation where you may consider color for internal purpo ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a es would be for the production of safety messages. These need to stand out and be noticed. Finally remember:
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r too much colored text. You may lose the impact and readability of the work. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin te. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen awing..for selling in particular. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e, stick to it throughout the document or presentation. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust etc, don't forget to explain what the colors mean though! y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products he copy! . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de st on various samples before settling on your final selection. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nd the impact factors.
This article may be reproduced in its entirety provided the resource paragraph below is included and all urls kept active tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Choosing A Good Name For Your Product or Service Keeping Your Customers through Loyalty Marketing
|